Emblaveo
FDA Approves AbbVie’s Emblaveo for Complicated Intra-Abdominal Infections
Emblaveo, aztreonam, avibactam, antibiotic resistance, Gram-negative bacteria, intra-abdominal infections, AbbVie
Actionable Insights Powered by AI
Emblaveo, aztreonam, avibactam, antibiotic resistance, Gram-negative bacteria, intra-abdominal infections, AbbVie